Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

64.65 +6.07 (+10.36%)
Official Closing Price Updated: 7:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
27 28 Next >
Hims & Hers Health's Model 'Proving Effective': 2 Analysts Examine Q1 Earnings
Hims & Hers Health reported total revenue of $278.2 million, a 46% year-on-year growth and higher than Street expectations of $270.4 million. 
Via Benzinga
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Hims & Hers Health Stock Could Become a Wealth Compounder
Hims & Hers stock could give investors the best of both stability and double-digit upside through EPS projections and price targets, especially after 1Q24 
Via MarketBeat
Topics Economy
Exposures Economy
Breaking Down Hims & Hers Health: 6 Analysts Share Their Views
Via Benzinga
A Closer Look at Hims & Hers Health's Options Market Dynamics
Via Benzinga
Check Out What Whales Are Doing With HIMS
Via Benzinga
Looking Into Hims & Hers Health's Recent Short Interest
Via Benzinga
Why Zeta Global Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on for Tuesday! 
Via InvestorPlace
Palantir, Boeing, Lucid Group, Hims & Hers, Tesla: Why These 5 Stocks Are On Investors' Radars Today
On Monday, major U.S. stock indexes experienced gains, with the S&P500 closing nearly 1% higher at 5,180.74 
Via Benzinga
HIMS Stock Earnings: Hims & Hers Health Beats EPS, Beats Revenue for Q1 2024
HIMS stock results show that Hims & Hers Health beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Hims & Hers Health Reports Better-Than-Expected Q1 Results, Strong Guidance
Hims & Hers Health reported quarterly GAAP earnings of 5 cents per share which beat the analyst consensus estimate of 2 cents by 150%. 
Via Benzinga
Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Health CEO Under Fire After Expressing Support For Pro-Palestinian Student Protesters, Company Stock Plummets
Hims & Hers Health Inc. (NYSE: HIMS) stock was hit significantly on Friday following its CEO's public support for pro-Palestinian protesters. 
Via Benzinga
Why Hims & Hers Stock Was Down This Week
An analyst feels that the bull run into the company has made it pricey on its valuations. 
Via The Motley Fool
The Disruptor’s Portfolio: 3 Stocks Shaping the New Economy
Leading the future economy, three disruptive stocks innovate with SoCs, strategic alliances, and digital health growth. 
Via InvestorPlace
Topics Economy
Exposures Economy
Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
From Hims & Hers Health, Inc.
Via Business Wire
Got $2,000? 2 Unbelievable Growth Stocks Up 58% and 30% to Buy in the New Bull Market
These stocks are on fire right now. 
Via The Motley Fool
Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member
From Hims & Hers Health, Inc.
Via Business Wire
Lamb Weston Reports Weak Earnings, Joins Paragon 28, Resources Connection And Other Big Stocks Moving Lower On Thursday
U.S. stocks were higher, with the Dow Jones gaining over 150 points on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
3 Disruptive Healthcare Stocks That Could Surge 1000% By 2028
Discover the untapped potential of disruptive healthcare stocks, capitalizing on transformative healthcare technology and delivery. 
Via InvestorPlace
3 Stocks With Unusual Call Option Activity
Three stocks reported rising call option buying activity could see even higher prices soon. Analysts see the writing on the wall, and traders stampeded in 
Via MarketBeat
Topics Economy
Exposures Interest Rates
LifeMD Shares Come Back to Life on GLP-1 Business Growth
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024 
Via MarketBeat
3 Stocks That Could Benefit from the Rise of Telemedicine
With growing demand, the market for telemedicine stocks could be worth about $450 billion by the time 2032 rolls around. 
Via InvestorPlace
3 Market-Disrupting Stocks Primed for a 400% Leap in the Next 2 Years
Here are three market-disrupting stocks with growth prospects in healthcare services, hotels, resorts, cruise lines, and systems software. 
Via InvestorPlace
Can WeightWatchers Regain its Mojo after Oprah Steps Down?
WW International Inc. (NASDAQ: WW) (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD). 
Via MarketBeat
Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024
From Hims & Hers Health, Inc.
Via Business Wire
3 Meme Stocks that r/WallStreetBets Loves (but Shouldn’t!)
Meme stocks promoted by r/WallStreetBets posts made gains for a number of investors in the past, but these stock plays are likely to fail. 
Via InvestorPlace
2 Telehealth Stocks to Buy Hand Over Fist in March
At combined market caps of less than $6 billion, these are a couple of dirt-cheap stocks to buy right now. 
Via The Motley Fool
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.